Zobrazeno 1 - 10
of 56
pro vyhledávání: '"H. van Ooijen"'
Autor:
A. Creemers, A. P. van der Zalm, A. van de Stolpe, L. Holtzer, M. Stoffels, G. K. J. Hooijer, E. A. Ebbing, H. van Ooijen, A. G. C. van Brussel, E. M. G. Aussems-Custers, M. I. van Berge Henegouwen, M. C. C. M. Hulshof, J. J. G. H. M. Bergman, S. L. Meijer, M. F. Bijlsma, H. W. M. van Laarhoven
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-11 (2022)
Abstract In this study we aimed to investigate signaling pathways that drive therapy resistance in esophageal adenocarcinoma (EAC). Paraffin-embedded material was analyzed in two patient cohorts: (i) 236 EAC patients with a primary tumor biopsy and c
Externí odkaz:
https://doaj.org/article/b796bd80452e4486bd3a67a7544d6df4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
J. Immunother Cancer
Autor:
H. van Ooijen, A. van Brussel, F Beca, KH Allison, Daniel L. Rubin, Alfiia Galimzianova, DM Cohn, S.S. Yang, A. van de Stolpe
Publikováno v:
Cancer Research. 79:P5-11
Background: Immunohistochemistry (IHC) staining for ER and progesterone (PR) receptors in breast cancer tissue is the current standard for testing for eligibility for hormone targeted therapies. However, these markers are imperfect predictors of resp
Autor:
C Dam, M Dou, Marten Hornsveld, A. van de Stolpe, Wim Verhaegh, H. van Ooijen, Boudewijn M.T. Burgering, A Eijkelenboom, Rick Velter
Publikováno v:
Cancer Research. 78:P2-09
Introduction The PI3K signaling pathway is frequently active in breast cancer, and therapeutic inhibitors have been developed. However, it has proven difficult to correctly predict treatment response. We developed a method that measures functional ac
Autor:
A. van Brussel, F van Hemert, H. van Ooijen, E. den Biezen-Timmermans, David Halter, Rick Velter, A. van de Stolpe, MA de Inda, J. van der Ven, P. van de Wiel, Reinhold Wimberger-Friedl
Publikováno v:
Cancer Research. 77:P1-06
This abstract was withdrawn by the authors.
Autor:
Yvonne Wesseling-Rozendaal, Martijn Akse, Márcia Alves De Inda, A. van Brussel, H. van Ooijen, E. den Biezen-Timmermans, Wim Verhaegh, H. van Zon, Anke Pierik
Publikováno v:
European Journal of Cancer. 138:S88-S89
Autor:
H. van Ooijen, Maarten F. Bijlsma, Laurent Holtzer, E.M.G. Aussems-Custers, M. Stoffels, M. I. van Berge Henegouwen, H.W.M. van Laarhoven, A. van Brussel, Sheila K. Krishnadath, Aafke Creemers, Maarten C.C.M. Hulshof, A. van de Stolpe, Sybren L. Meijer
Publikováno v:
Annals of Oncology. 30:v316
Background To reveal candidate signaling pathways for targeted therapy in esophageal cancer (EC), and esophageal adenocarcinoma (EAC) in particular, we investigated key signal transduction pathways in material available in clinical routine, before an
Autor:
Gerrit K. J. Hooijer, H.W.M. van Laarhoven, A. van Brussel, H. van Ooijen, A. van de Stolpe, Aafke Creemers, Maarten F. Bijlsma, E.M.G. Aussems-Custers, Laurent Holtzer, Maarten C.C.M. Hulshof, M. Stoffels, M. I. van Berge Henegouwen, Sybren L. Meijer, Kausilia K. Krishnadath
Publikováno v:
Annals of Oncology. 29:viii211